Bioventus Bioventus
  • Our Company
    • About Bioventus
    • Leadership
    • Board Members
    • Partnerships
    • Grants Committee
    • Compliance
  • Products
    • Ultrasound Bone Healing
    • Joint Therapies
    • Bioventus Surgical
  • Patients
    • Active Healing
    • Effective Therapies
    • Additional Patient Info
  • Physicians
    • Biologics
    • Less Invasive Solutions
    • Investigator Initiated Study Request
    • Upcoming Events
    • Medical Education
  • Payers
    • Biologics
    • Minimize Costs
  • News
    • News Releases
    • Download Library
  • Careers
  • Contact Us
  • Get back on track with our
    innovative treatments & accurately
    target the source of pain.

    Read More
    Engage and
    Enhance the
    Natural
    Healing
    Process
    PATIENTS
  • The Power of
    Biologics in
    Orthopaedic
    Care
    Provide your patients with less
    invasive and effective treatment
    options with our clinically proven
    therapies.

    Read More
    PHYSICIANS
  • Therapies That
    Are Both
    Innovative and
    Cost-effective
    Bioventus offers cost-effective
    alternatives to surgery, which have
    been shown to speed recovery and
    reduce the need for invasive
    procedures.

    Read More
    PAYERS
Home Bioventus 2017-12-11T21:55:24+00:00

IN THE NEWS
.

Bioventus to Co-Develop Next Generation Bone Allograft with LifeLink

Bioventus to Continue Distributing SUPARTZ FX Through 2028

Previous 1 2 3 4 5 Next

BONES Studies Information

Announced in March of 2017, Bioventus has commissioned an innovative series of clinical studies to further validate the ability of the EXOGEN® Ultrasound Bone Healing System to mitigate the risk of a fracture progressing to nonunion in the presence of known risk factors.

Read More
study_3_0

ICD-10 Information

Beginning October 1, 2015 everyone covered by the Health Insurance Portability Accountability Act (HIPAA) is required to begin submitting claims using ICD-10 diagnostic coding.

Read More

OUR COMPANY

About Bioventus
Leadership
Board Members
Partnerships
Grants Committee
Compliance


CAREERS
CONTACT US



Bioventus adheres to the AdvaMed Code of Ethics

PRODUCTS

Ultrasound Bone Healing
Joint Therapies
Bioventus Surgical

PATIENTS

Active Healing
Effective Therapies
Additional Patient Info

NEWS

News Announcements
Download Library

PHYSICIANS

Biologics for Physicians
Less Invasive Solutions
Investigator Initiated Study
MedEd Events
Upcoming Events
Journal Library


STAY CONNECTED

PAYERS

Biologics for Payers
Minimize Costs
Code Glossary

BIONET

©2016 Bioventus. All rights reserved. Terms of Use | Copyright & Disclaimer
Bioventus, the Bioventus logo, DUROLANE and EXOGEN are registered trademark of Bioventus LLC.
GELSYN-3 is a trademark of Bioventus LLC.
SUPARTZ FX is a registered trademark of Seikagaku Corp.
All other trade names referenced are the trademarks or registered trademarks of their respective companies.